Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diastolic Heart Failure.

Zile1, Nappi

  • 1Division of Cardiology, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 816, PO Box 250625, Charleston, SC 29425-5799, USA. zilem@musc.edu.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transverse momentum dependence of Bose-Einstein correlations in 200A GeV/cS+A collisions.

Physical review letters·1995
Same author

Charged particle spectra in central S+S collisions at 200 GeV/c per nucleon.

Physical review letters·1994
Same author

Investigation of subgap structures in high-quality Nb/AlOx/Nb tunnel junctions.

Physical review. B, Condensed matter·1994
Same author

Wess-Zumino-Witten model based on a nonsemisimple group.

Physical review letters·1993
Same author

Duality, marginal perturbations, and gauging.

Physical review. D, Particles and fields·1993
Same author

Simultaneous observation of extensive air showers and deep-underground muons at the Gran Sasso Laboratory.

Physical review. D, Particles and fields·1990
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Diastolic heart failure (DHF) is a common cause of heart failure with preserved ejection fraction, affecting up to 50% of patients. Effective management involves targeting symptoms, underlying diseases, and future mechanisms to improve outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Diastolic heart failure (DHF) is a frequent cause of congestive heart failure (CHF), accounting for 35% to 50% of cases.
  • DHF significantly impacts patient mortality and morbidity, with a 5-year mortality rate of 25% to 35% and a 1-year readmission rate of 50%.

Purpose of the Study:

  • To outline the diagnostic criteria for DHF, emphasizing symptoms, physical exam findings, and diastolic function.
  • To detail current and future therapeutic strategies for DHF, focusing on symptom, disease, and mechanism-targeted approaches.

Main Methods:

  • Diagnosis involves identifying CHF symptoms and signs with normal left ventricular volume and ejection fraction.
  • Treatment strategies encompass symptom relief, management of causal diseases like ischemia and hypertrophy, and future mechanism-based therapies.

Related Experiment Videos

Main Results:

  • Abnormal diastolic function confirms DHF but is not mandatory for diagnosis.
  • Symptom management includes diuretics, nitrates, heart rate reduction (beta-blockers, calcium channel blockers), and improved exercise tolerance (ACE inhibitors, ARBs).

Conclusions:

  • DHF is a prevalent and serious condition requiring multifaceted treatment.
  • Future therapies aim to target neurohumoral activation and intracellular pathways for improved patient outcomes.